髄膜炎診断検査の市場規模、シェア＆動向分析レポート：テストタイプ別（ラテックス凝集テスト、ラテラルフローアッセイ、PCRアッセイ、ELISAテスト、培養テスト）、エンドユーザー別、地域別、セグメント別予測、2023年～2030年

髄膜炎診断検査市場の成長と動向

Grand View Research, Incの最新レポートによると、髄膜炎診断テストの世界市場規模は2030年までに1億5406万米ドルに達し、予測期間中に3.68%のCAGRを記録する見込みであることが明らかになりました。市場の成長は、病気の早期診断に関する人々の意識の高まりと、検査の高い精度と相まって迅速な診断への需要が高まっていることに起因しています。さらに、疾病の負担を軽減するための政府支援の増加や診断センター数の増加も、市場の需要を高める要因となっています。

感染症やHIVの蔓延は髄膜炎発症のリスクを高め、世界中で髄膜炎診断検査に対する需要を高めています。例えば、WHOによると、2021年には世界で3,840万人以上がHIVと共存しています。また、2020年のCDCによると、米国では約30,635人がHIVの診断を受けており、HIV感染者数の多さは髄膜炎の検査率を高める可能性があります。さらに、EV髄膜炎は、米国で毎年約30,000～50,000人の入院を引き起こすと推定されています。

このように、対象となる疾患の発生率が高いことから、メーカーは正確な診断ソリューションの開発に取り組んでいます。例えば、セファイド社は、最適な感度と特異度で2.5時間で結果が得られる高速分子体外診断用医薬品Xpert EVを提供しています。同様に、Diagenode Diagnostics社のM-DiaMultは、Neisseria meningitidisを含む多くの細菌感染症を検出するPCR-CE-IVDキットの一種です。

髄膜炎は、その長期的な影響と高い死亡率から、世界の問題となっています。政府は、髄膜炎を撲滅するために、高度な診断検査や治療法の提供を積極的に支援しています。例えば、髄膜炎研究財団やCDCは、結核、マラリア、髄膜炎など、病院では受けることのできないさまざまな感染症の診断サービスを提供しています。このように、さまざまな感染症の診断を促進するための政府の取り組みは、市場に有利な成長機会を提供する可能性があります。

さらに、ヘルスケア分野の開発の急増と診断検査の技術的進歩の高まりは、市場に強固な成長機会を提供すると思われます。例えば、2022年7月、分子診断検査のリーダーであるAbacus Diagnosticaは、脳炎や髄膜炎を引き起こすウイルスを迅速に特定するための新しい高速PCR検査を欧州市場で発売しました。この新発売の検査により、医療従事者は髄膜炎を引き起こす最も一般的なウイルスを70分という短時間で特定することができます。精度の高い迅速な検査の導入は、今後数年間の市場成長を促進すると予想されます。

髄膜炎診断検査市場レポートハイライト

PCRアッセイセグメントは、PCRテストへの高い嗜好性、高い感度と低い検査所要時間により、2022年に最大の市場シェアを占めた

ラテラルフローアッセイは、さまざまなヘルスケア施設での迅速検査の採用が進んでいることから、今後数年間で最も速いペースで成長すると予想される

病院部門は基準年度において売上高に最も貢献しており、その高い売上高は新しい診断技術へのアクセスの増加や医療保障の向上に起因する

診断センター分野は、感染症の急増と先進的な製品の採用増加により、最も速い成長率を示すと予想される

アジア太平洋地域は、同地域での投資の増加や臨床試験の進行により、予測期間中に最も速い成長を示すと予想される

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース：
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ：商品フローアプローチ
• 調査の仮定
• 二次情報一覧
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• 競合考察

第3章 髄膜炎診断検査市場の変数、動向、および範囲

• 市場系列の見通し
  • 親市場
• 市場力学
  • 市場促進要因分析
    • 髄膜炎の有病率の増加
    • 革新的技術別迅速診断の需要の高まり
    • 髄膜炎疾患の発生を制御するための政府の積極的な支援
  • 市場抑制要因分析
    • 厳格な規制の枠組み
• 浸透と成長の見通しのマッピング
• 髄膜炎診断検査：市場分析ツール
  • 業界分析- ポーターズ
  • PESTLE分析
• 規制の枠組み
• 価格分析

第4章 髄膜炎診断検査市場セグメント分析、検査タイプ別、2018年～2030年（100万米ドル）

• 定義と範囲
• テストタイプの市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 2018年から2030年までのテストタイプ別の世界の髄膜炎診断テスト市場
• 市場規模と予測、トレンド分析、2018年から2030年
  • ラテックス凝集
  • ラテラルフローアッセイ
  • PCRアッセイ
  • ELISAテスト
  • 培養試験
  • その他

第5章 髄膜炎診断検査市場セグメント分析、エンドユーザー別、2018年～2030年（100万米ドル）

• 定義と範囲
• エンドユーザーの市場シェア分析、2022年および2030年
• セグメントダッシュボード
• 世界の髄膜炎診断検査市場、エンドユーザー別、2018年から2030年
• 市場規模と予測、トレンド分析、2018年から2030年
  • 病院
  • 診断センター
  • その他

第6章 髄膜炎診断検査市場セグメント分析、地域別、2018年から2030年（100万米ドル）

• 定義と範囲
• 地域市場シェア分析、2022年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場規模、予測、収益、トレンド分析、2018年から2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 髄膜炎診断検査市場-競合分析

• 主要な市場参入企業別最近の動向と影響分析
  • Ansoff matrix
  • Heat map analysis
  • Major Deals and Strategic Alliances Analysis
    • 合弁事業
    • ライセンシング契約
    • 製品の発売
    • カンファレンスとキャンペーン
• 会社の分類
  • イノベーター
  • 市場のリーダー
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
• 公開会社
  • 競合ダッシュボード分析
    • 市場の差別化要因
• 非公開会社
  • 主要新興企業一覧
• 企業プロファイル
  • Thermo Fisher Scientific, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Bio-Rad Laboratories, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Abbott
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • ELITechGroup
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Seegene Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Luminex Corporation
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • CERTEST BIOTEC
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • IMMY
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Uniogen Oy
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Leading Market Players Anticipated to Witness Highest Growth
• Table 4 Global Meningitis Diagnostic Testing Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 6 Global Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 7 North America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
• Table 8 North America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 9 North America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 10 U.S. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 11 U.S. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 12 Canada Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 13 Canada Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 14 Europe Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
• Table 15 Europe Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 16 Europe Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 17 U.K. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 18 U.K. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 19 Germany Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 20 Germany Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 21 France Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 22 France Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 23 Spain Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 24 Spain Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 25 Italy Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 26 Italy Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 27 Denmark Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 28 Denmark Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 29 Norway Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 30 Norway Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 31 Sweden Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 32 Sweden Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 33 Asia Pacific Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
• Table 34 Asia Pacific Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 35 Asia Pacific Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 36 Japan Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 37 Japan Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 38 China Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 39 China Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 40 India Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 41 India Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 42 Australia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 43 Australia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 44 South Korea Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 45 South Korea Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 46 Thailand Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 47 Thailand Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 48 Latin America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
• Table 49 Latin America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 50 Latin America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 51 Brazil Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 52 Brazil Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 53 Argentina Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 54 Argentina Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 55 Mexico Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 56 Mexico Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 57 Middle East and Africa Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
• Table 58 Middle East and Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 59 Middle East and Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 60 South Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 61 South Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 62 Saudi Arabia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 63 Saudi Arabia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 64 UAE Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 65 UAE Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
• Table 66 Kuwait Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
• Table 67 Kuwait Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Meningitis diagnostic testing market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2022)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Meningitis Diagnostic Testing market: Test type movement analysis
• Fig. 17 Meningitis Diagnostic Testing market: Test type segment dashboard
• Fig. 18 Meningitis Diagnostic Testing market Test type outlook: Key takeaways
• Fig. 19 Latex agglutination market, 2018 - 2030 (USD million)
• Fig. 20 Lateral flow assay market, 2018 - 2030 (USD million)
• Fig. 21 PCR assay market, 2018 - 2030 (USD million)
• Fig. 22 ELISA tests market, 2018 - 2030 (USD million)
• Fig. 23 Culture test market, 2018 - 2030 (USD million)
• Fig. 24 Others market, 2018 - 2030 (USD million)
• Fig. 25 Meningitis Diagnostic Testing market: End-user analysis
• Fig. 26 Meningitis Diagnostic Testing market: End-user segment dashboard
• Fig. 27 Meningitis Diagnostic Testing market End-user outlook: Key takeaways
• Fig. 28 Hospitals market, 2018 - 2030 (USD million)
• Fig. 29 Diagnostic centers market, 2018 - 2030 (USD million)
• Fig. 30 Others market, 2018 - 2030 (USD million)
• Fig. 31 Regional outlook, 2022 & 2030
• Fig. 32 Regional market dashboard
• Fig. 33 Regional market place: Key takeaways
• Fig. 34 North America, SWOT
• Fig. 35 Europe, SWOT
• Fig. 36 Asia Pacific, SWOT
• Fig. 37 Latin America, SWOT
• Fig. 38 Middle East and Africa, SWOT
• Fig. 39 North America
• Fig. 40 North America meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 41 U.S.
• Fig. 42 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 43 Canada
• Fig. 44 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 45 Europe
• Fig. 46 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 47 U.K.
• Fig. 48 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 49 Germany
• Fig. 50 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 51 Spain
• Fig. 52 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 53 France
• Fig. 54 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 55 Italy
• Fig. 56 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 57 Denmark
• Fig. 58 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 59 Sweden
• Fig. 60 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 61 Norway
• Fig. 62 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 63 Asia Pacific
• Fig. 64 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 65 Japan
• Fig. 66 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 67 China
• Fig. 68 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 69 India
• Fig. 70 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 71 South Korea
• Fig. 72 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 73 Australia
• Fig. 74 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 75 Thailand
• Fig. 76 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 77 Latin America
• Fig. 78 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 79 Brazil
• Fig. 80 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 81 Mexico
• Fig. 82 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 83 Argentina
• Fig. 84 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 85 Middle East and Africa
• Fig. 86 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 87 South Africa
• Fig. 88 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD Million)
• Fig. 89 Saudi Arabia
• Fig. 90 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 91 UAE
• Fig. 92 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 93 Kuwait
• Fig. 94 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)
• Fig. 95 Ansoff Matrix
• Fig. 96 Heat map analysis
• Fig. 97 Market differentiators

Meningitis Diagnostic Testing Market Growth & Trends:

The global meningitis diagnostic testing market size is expected to reach USD 154.06 million by 2030, according to a new report by Grand View Research, Inc, registering a CAGR of 3.68% over the forecast period. The growth of the market is accredited to the rising awareness among the people about early disease diagnosis and increasing demand for rapid diagnosis coupled with the high accuracy of the test. Moreover, the increasing government support to reduce the burden of disease and the rising number of diagnostic centers are other factors fueling market demand.

The increasing prevalence of infectious diseases, and HIV is increasing the risk of developing meningitis, which is increasing the demand for meningitis diagnostic tests, worldwide. For instance, according to the WHO, over 38.4 million people were living with HIV worldwide in 2021. In addition, according to CDC in 2020, around 30,635 people received HIV diagnoses in the U.S. High number of HIV infections may increase the testing rate for meningitis. Moreover, EV meningitis is estimated to result in around 30,000-50,000 hospitalizations every year in the U.S.

Thus, such a high incidence of target diseases is pushing manufacturers to develop precise diagnostic solutions. For instance, Cepheid offered Xpert EV, a fast molecular in vitro diagnostic EV test, which provides results in 2.5 hours with optimum sensitivity and specificity. Similarly, M-DiaMult of Diagenode Diagnostics is a type of PCR- CE-IVD kit that detects many bacterial infections including Neisseria meningitidis.

Meningitis infection has emerged as a global issue owing to its long-term consequences and high mortality rate. The government is offering active support to provide sophisticated diagnostic tests and treatment regimens to eradicate the disease. For instance, the Meningitis Research Foundation and the CDC offer referral diagnoses for different infectious diseases such as tuberculosis, malaria, and meningitis among others that are not available in hospitals. Thus, such government initiatives to promote the diagnosis of various infectious diseases are likely to offer lucrative growth opportunities for the market.

Furthermore, the surge in the healthcare sector developments and growing technological advancements in diagnostic tests are likely to offer robust growth opportunities for the market. For instance, in July 2022, Abacus Diagnostica, a leader in molecular diagnostic testing, launched a novel rapid PCR test in Europe markets for the quick identification of viruses causing encephalitis and meningitis. This newly launched test allows healthcare professionals to identify the most common virus those causes meningitis in a span of 70 minutes. The introduction of rapid tests with high accuracy is anticipated to propel the market growth in the coming years.

Meningitis Diagnostic Testing Market Report Highlights:

• PCR assay segment held the largest market share in 2022 owing to a high preference for PCR tests and higher sensitivity and lower turnaround times of the test

• Lateral flow assay is expected to be the fastest segment during the coming years due to the increasing adoption of rapid tests at different healthcare facilities

• Hospitals segment was the leading revenue contributor during the base year and its high revenue is attributed to increasing access to novel diagnostic technologies and improved healthcare coverage

• The diagnostic centers segment is anticipated to exhibit the fastest growth rate owing to the surge in the burden of infectious diseases and the increasing adoption of technologically advanced products

• Asia Pacific is expected to exhibit the fastest growth over the forecast period due to rising investments in the region and ongoing trials in the region

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Competitive Insights

Chapter 3 Meningitis Diagnostic Testing Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market
• 3.2 Market Dynamics
  • 3.2.1 Market drivers analysis
    • 3.2.1.1 Increasing prevalence of meningitis
    • 3.2.1.2 Rise in demand for rapid diagnosis by using innovative technologies
    • 3.2.1.3 Active government support to control meningitis disease outbreak
  • 3.2.2 Market restraint analysis
    • 3.2.2.1 Stringent regulatory framework
• 3.3 Penetration & Growth Prospect Mapping
• 3.4 Meningitis Diagnostic Testing: Market Analysis Tools
  • 3.4.1 Industry analysis - Porter's
  • 3.4.2 PESTLE analysis
• 3.5 Regulatory Framework
• 3.6 Pricing Analysis

Chapter 4 Meningitis Diagnostic Testing Market Segment Analysis, By Test Type, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Test Type Market Share Analysis, 2022 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Meningitis Diagnostic Testing Market, by Test Type, 2018 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.5.1 Latex Agglutination
    • 4.5.1.1 Latex agglutination market, 2018 - 2030 (USD million)
  • 4.5.2 Lateral Flow Assay
    • 4.5.2.1 Lateral flow assay market, 2018 - 2030 (USD million)
  • 4.5.3 PCR Assay
    • 4.5.3.1 PCR assay market, 2018 - 2030 (USD million)
  • 4.5.4 ELISA Tests
    • 4.5.4.1 ELISA tests market, 2018 - 2030 (USD million)
  • 4.5.5 Culture Test
    • 4.5.5.1 Culture test market, 2018 - 2030 (USD million)
  • 4.5.6 Others
    • 4.5.6.1 Others market, 2018 - 2030 (USD million)

Chapter 5 Meningitis Diagnostic Testing Market Segment Analysis, By End-User 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 End-User Market Share Analysis, 2022 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Meningitis Diagnostic Testing Market, by End-User, 2018 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5.1 Hospitals
    • 5.5.1.1 Hospitals market, 2018 - 2030 (USD million)
  • 5.5.2 Diagnostic Centers
    • 5.5.2.1 Diagnostic centers market, 2018 - 2030 (USD million)
  • 5.5.3 Others
    • 5.5.3.1 Others market, 2018 - 2030 (USD million)

Chapter 6 Meningitis Diagnostic Testing Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 6.1 Definition & Scope
• 6.2 Regional Market Share Analysis, 2022 & 2030
• 6.3 Regional Market Dashboard
• 6.4 Regional Market Snapshot
• 6.5 SWOT Analysis
  • 6.5.1 North America
  • 6.5.2 Europe
  • 6.5.3 Asia Pacific
  • 6.5.4 Latin America
  • 6.5.5 Middle East and Africa
• 6.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
  • 6.6.1 North America
    • 6.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD million)
    • 6.6.1.2 U.S.
    • 6.6.1.2.1 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.1.3 Canada
    • 6.6.1.3.1 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • 6.6.2 Europe
    • 6.6.2.1 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2.2 U.K.
    • 6.6.2.2.1 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2.3 Germany
    • 6.6.2.3.1 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2.4 Spain
    • 6.6.2.4.1 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2.5 France
    • 6.6.2.5.1 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2.6 Italy
    • 6.6.2.6.1 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2.7 Denmark
    • 6.6.2.7.1 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2.8 Sweden
    • 6.6.2.8.1 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2.9 Norway
    • 6.6.2.9.1 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • 6.6.3 Asia Pacific
    • 6.6.3.1 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3.2 Japan
    • 6.6.3.2.1 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3.3 China
    • 6.6.3.3.1 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3.4 India
    • 6.6.3.4.1 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3.5 South Korea
    • 6.6.3.5.1 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3.6 Australia
    • 6.6.3.6.1 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3.7 Thailand
    • 6.6.3.7.1 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • 6.6.4 Latin America
    • 6.6.4.1 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.4.2 Brazil
    • 6.6.4.2.1 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.4.3 Mexico
    • 6.6.4.3.1 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.4.4 Argentina
    • 6.6.4.4.1 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • 6.6.5 MEA
    • 6.6.5.1 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.5.2 South Africa
    • 6.6.5.2.1 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.5.3 Saudi Arabia
    • 6.6.5.3.1 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.5.4 UAE
    • 6.6.5.4.1 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.5.5 Kuwait
    • 6.6.5.5.1 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)

Chapter 7 Meningitis Diagnostic Testing Market - Competitive Analysis

• 7.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 7.1.1 Ansoff matrix
  • 7.1.2 Heat map analysis
  • 7.1.3 Major Deals and Strategic Alliances Analysis
    • 7.1.3.1 Joint Ventures
    • 7.1.3.2 Licensing Agreements
    • 7.1.3.3 Product Launches
    • 7.1.3.1 Conferences and Campaigns
• 7.2 Company Categorization
  • 7.2.1 Innovators
  • 7.2.2 Market Leaders
• 7.3 Vendor Landscape
  • 7.3.1 List of key distributors and channel partners
  • 7.3.2 Key customers
• 7.4 Public Companies
  • 7.4.1 Competitive Dashboard Analysis
    • 7.4.1.1 Market Differentiators
• 7.5 Private Companies
  • 7.5.1 List of key emerging companies
• 7.6 Company Profiles
  • 7.6.1 Thermo Fisher Scientific, Inc.
    • 7.6.1.1 Company overview
    • 7.6.1.2 Financial performance
    • 7.6.1.3 Product benchmarking
    • 7.6.1.4 Strategic initiatives
  • 7.6.2 Bio-Rad Laboratories, Inc.
    • 7.6.2.1 Company overview
    • 7.6.2.2 Financial performance
    • 7.6.2.3 Product benchmarking
    • 7.6.2.4 Strategic initiatives
  • 7.6.3 Abbott
    • 7.6.3.1 Company overview
    • 7.6.3.2 Financial performance
    • 7.6.3.3 Product benchmarking
    • 7.6.3.4 Strategic initiatives
  • 7.6.4 ELITechGroup
    • 7.6.4.1 Company overview
    • 7.6.4.2 Financial performance
    • 7.6.4.3 Product benchmarking
    • 7.6.4.4 Strategic initiatives
  • 7.6.5 Seegene Inc.
    • 7.6.5.1 Company overview
    • 7.6.5.2 Financial performance
    • 7.6.5.3 Product benchmarking
    • 7.6.5.4 Strategic initiatives
  • 7.6.6 Luminex Corporation
    • 7.6.6.1 Company overview
    • 7.6.6.2 Financial performance
    • 7.6.6.3 Product benchmarking
    • 7.6.6.4 Strategic initiatives
  • 7.6.7 CERTEST BIOTEC
    • 7.6.7.1 Company overview
    • 7.6.7.2 Financial performance
    • 7.6.7.3 Product benchmarking
    • 7.6.7.4 Strategic initiatives
  • 7.6.8 IMMY
    • 7.6.8.1 Company overview
    • 7.6.8.2 Financial performance
    • 7.6.8.3 Product benchmarking
    • 7.6.8.4 Strategic initiatives
  • 7.6.9 Uniogen Oy
    • 7.6.9.1 Company overview
    • 7.6.9.2 Financial performance
    • 7.6.9.3 Product benchmarking
    • 7.6.9.4 Strategic initiatives